Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants
Home
Publications
Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants
Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants
Authors:
TA
T. Asselah
T. Asselah
SP
S. Pol
S. Pol
CH
C. Hezode
C. Hezode
VL
V. Loustaud-Ratti
V. Loustaud-Ratti
VL
V. Leroy
V. Leroy
SA
S.N.S. Ahmed
S.N.S. Ahmed
VO
V. Ozenne
V. Ozenne
JB
J.-P. Bronowicki
J.-P. Bronowicki
DL
D. Larrey
D. Larrey
AT
A. Tran
A. Tran
LA
L. Alric
L. Alric
EN
E. Nguyen-Khac
E. Nguyen-Khac
See more
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Publisher website
Google Scholar
1 April 2018
journal article
abstracts
Published by
Elsevier
in
Journal of Hepatology
Vol. 68
,
S3-S4
DOI:
10.1016/s0168-8278(18)30225-3
Abstract
No abstract available
Cited
Cited by 3 articles
Scroll to top